EssilorLuxottica Société anonyme (EPA: EL)
France
· Delayed Price · Currency is EUR
231.20
-0.70 (-0.30%)
Dec 20, 2024, 5:35 PM CET
EPA: EL Revenue
EssilorLuxottica Société anonyme had revenue of 13.29B EUR in the half year ending June 30, 2024, with 10.81% growth. This brings the company's revenue in the last twelve months to 25.83B, up 1.91% year-over-year. In the year 2023, EssilorLuxottica Société anonyme had annual revenue of 25.40B with 3.68% growth.
Revenue (ttm)
25.83B
Revenue Growth
+1.91%
P/S Ratio
4.04
Revenue / Employee
133.38K
Employees
151,292
Market Cap
105.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
Dec 31, 2019 | 17.39B | 6.56B | 60.53% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Eurofins Scientific SE | 6.72B |
Ipsen S.A. | 3.44B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |
Vetoquinol SA | 537.47M |
EssilorLuxottica Société anonyme News
- 2 days ago - EssilorLuxottica and Prada extend eyewear licensing agreement - Reuters
- 2 days ago - EssilorLuxottica: Prada Group and EssilorLuxottica announce ten-years licensing renewal - GlobeNewsWire
- 5 days ago - EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space - GlobeNewsWire
- 9 days ago - EssilorLuxottica: EssilorLuxottica's greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi) - GlobeNewsWire
- 15 days ago - OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative - GlobeNewsWire
- 15 days ago - OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative - GlobeNewsWire
- 22 days ago - EssilorLuxottica: Valuation Is Too High, Neutral Rating Confirmed - Seeking Alpha
- 6 weeks ago - Acquisition speculation grips European luxury: Meta said to eye 5% stake in Ray-Ban maker, Moncler linked to Burberry takeover - Fortune